☆ 4.7 Editorial Material

Defective Mismatch Repair in Colon Cancer: A Prognostic Or Predictive Biomarker?

JOURNAL OF CLINICAL ONCOLOGY (2010)

期刊

JOURNAL OF CLINICAL ONCOLOGY

卷 28, 期 20, 页码 3210-3212

出版社

AMER SOC CLINICAL ONCOLOGY

DOI: 10.1200/JCO.2010.28.9322

关键词

-

类别

Oncology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Oncology

Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian)

Camille Evrard, Jerome Alexandre

Summary: Endometrial cancers are highly affected by microsatellite instability, showing sensitivity to immunotherapy and requiring molecular biology for better understanding. The phenotype is poorly understood in ovarian cancer but does exist. Examination of literature reveals the importance of deficient mismatch repair/microsatellite instability in gynecological cancers and the potential therapeutic and prognostic implications.

CANCERS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Identification of MKI67, TPR, and TCHH Mutations as Prognostic Biomarkers for Patients With Defective Mismatch Repair Colon Cancer Stage II/III

Jingfang Lv, Wenbin Li, Xintong Wang, Lei Guo, Dongliang Wang, Yiran Zhang, Jun Yu, Tianli Chen, Beifang Niu, Xishan Wang, Zheng Liu

Summary: This study aims to identify prognostic markers for patients with deficient mismatch repair/microsatellite instability-high colon cancer stage II/III. The study found that MKI67, TPR, and TCHH may serve as potential diagnostic and prognostic biomarkers for this disease. Patients with biomarker mutation-type colon cancer had a higher risk of recurrence or death and had more mutations in the DNA damage repair pathway and tumor mutational burden.

DISEASES OF THE COLON & RECTUM (2023)

添加到收藏夹

Review Oncology

Prognostic and Predictive Values of Mismatch Repair Deficiency in Non-Metastatic Colorectal Cancer

Zhaohui Jin, Frank A. Sinicrope

Summary: dMMR/MSI-H in non-metastatic CRC has important prognostic and predictive value, guiding patient management and treatment decisions in clinical practice.

CANCERS (2021)

添加到收藏夹

Article Genetics & Heredity

HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite Instability

Gaelle Tachon, Arnaud Chong-Si-Tsaon, Thierry Lecomte, Audelaure Junca, Eric Frouin, Elodie Miquelestorena-Standley, Julie Godet, Camille Evrard, Violaine Randrian, Romain Chautard, Marie-Luce Auriault, Valerie Moulin, Serge Guyetant, Gaelle Fromont, Lucie Karayan-Tapon, David Tougeron

Summary: The determination of microsatellite instability (MSI) and deficient mismatch repair (dMMR) in colorectal cancer (CRC) has important implications for management. This study evaluated the interest of HSP110 deletion/expression as a diagnostic tool for dMMR/MSI CRCs and a predictive tool for adjuvant chemotherapy efficacy. The results showed a strong correlation between HSP110 protein expression and the size of HSP110 T-17 deletion in MSI CRCs. HSP110 T-17 deletion was found to be an interesting marker for identifying discordant cases between MMR IHC and MSI.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers

Martina Amato, Renato Franco, Gaetano Facchini, Raffaele Addeo, Fortunato Ciardiello, Massimiliano Berretta, Giulia Vita, Alessandro Sgambato, Sandro Pignata, Michele Caraglia, Marina Accardo, Federica Zito Marino

Summary: Microsatellite instability (MSI) is common in cancer and predicts sensitivity to immune checkpoint inhibitors. Different MSI testing methods are used in clinical practice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Oncology

Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer

Kjersti Elvestad Hestetun, Nina Benedikte Rosenlund, Luka Stanisavljevic, Olav Dahl, Mette Pernille Myklebust

Summary: Deficient mismatch repair (dMMR) is associated with improved prognosis in stage II colon cancer but not in stage III colon cancer.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma

Yixi Li, Dehua Li, Yang Chen, Yongping Lu, Fangbin Zhou, Chunhong Li, Zhipeng Zeng, Wanxia Cai, Liewen Lin, Qiang Li, Mingjun Ye, Jingjing Dong, Lianghong Yin, Donge Tang, Gong Zhang, Yong Dai

Summary: By identifying prognostic biomarkers in the conserved and specific oncogenic pathway and its regulatory RNA network, researchers developed a seven-glycogene prognosis signature, GlycoSig, that can predict poor-prognostic subtype for pMMR CRAC patients. This biomarker set was validated in multicenter datasets, demonstrating its robustness and wide applicability.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Oncology

DNA damage repair mutations in pancreatic cancer- prognostic or predictive?

Ya-Fei Hu, Hai-Jie Hu, Heng-Chung Kung, Tian-Run Lv, Jun Yu, Fu-Yu Li

Summary: The efficacy of platinum-based chemotherapy (PtCh) for pancreatic cancer (PC) patients with DNA damage repair gene mutations (DDRm) remains uncertain. This study analyzed multiple studies and found that DDRm was associated with a longer overall survival (OS) in advanced-stage PC patients, regardless of PtCh exposure. The first-line PtCh (1L-PtCh) also improved progression-free survival (PFS) in advanced-stage PC with DDRm. However, for resected PC patients, the presence of DDRm did not significantly impact OS, whether they received PtCh or not. Further prospective trials are needed to verify the prognostic value of DDRm.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Review Immunology

Predictive biomarkers of colon cancer immunotherapy: Present and future

Wanting Hou, Cheng Yi, Hong Zhu

Summary: Immunotherapy has revolutionized colon cancer treatment, especially for patients with high microsatellite instability. In addition to microsatellite instability, other biomarkers have been proposed to be correlated with patient survival and immunotherapy efficacy, highlighting the importance of further search for predictive biomarkers in colon cancer immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy

Ziyu Li, Yinkui Wang, Xiangji Ying, Li Zhang, Xiangyu Gao, Yongning Jia, Lianhai Zhang, Aiwen Wu, Xiangqian Su, Jiafu Ji

Summary: This study with a large sample size found that deficient DNA mismatch repair (dMMR) status was not significantly associated with overall survival (OS) and disease-free survival (DFS) in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant and adjuvant platinum and fluorouracil-based chemotherapy.

JOURNAL OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure

Xiaosa Li, Lina Zhou, Bao-Qing Gao, Guangye Li, Xiao Wang, Ying Wang, Jia Wei, Wenyan Han, Zixian Wang, Jifang Li, Runze Gao, Junjie Zhu, Wenchao Xu, Jing Wu, Bei Yang, Xiaodong Sun, Li Yang, Jia Chen

Summary: In this study, the authors optimized the gene editing system to increase the efficiency of Prime editor by altering the secondary structure of the guide RNA and introducing mutations. The developed strategies achieved highly efficient Prime editing at previously uneditable sites.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer

Suisui Hao, Jingshan Tong, Anupma Jha, Denise Risnik, Darleny Lizardo, Xinyan Lu, Ajay Goel, Patricia L. Opresko, Jian Yu, Lin Zhang

Summary: Synthetic lethality can be used to target oncogenic drivers in cancer, and in this study, it was found that WRN helicase is required for the survival of MSI CRC cells. Depletion of WRN induces p53 and PUMA, leading to apoptosis in MSI CRC cells. The vulnerability of MSI CRCs to WRN loss is mediated by p53/PUMA-dependent apoptosis. WRN depletion or treatment with ML216 suppresses the growth of MSI CRCs in vitro and in vivo in a p53/PUMA-dependent manner.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review

Qasem Al-Tashi, Maliazurina B. Saad, Amgad Muneer, Rizwan Qureshi, Seyedali Mirjalili, Ajay Sheshadri, Xiuning Le, Natalie I. Vokes, Jianjun Zhang, Jia Wu

Summary: The identification of biomarkers is crucial in personalized medicine, but differentiating between predictive and prognostic biomarkers can be challenging due to overlap. Prognostic biomarkers predict cancer outcomes regardless of treatment, while predictive biomarkers assess the effectiveness of therapeutic interventions. Misclassifying them can have serious consequences for patients. This study provides an in-depth analysis of recent advancements, challenges, and future prospects in biomarker identification, using a systematic search of studies published between 2017 and 2023. The review aims to serve as a valuable resource for researchers in understanding biomarker discovery methods and identifying future research opportunities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Oncology

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma

Mikko Loukovaara, Annukka Pasanen, Ralf Butzow

Summary: In this retrospective study, the aggressiveness of MMR deficient endometrial carcinomas was examined. MMR deficiency was associated with poor disease-specific survival and increased risk of cancer-related death. The findings highlight the need for improved triage to adjuvant therapy and new therapeutic approaches in MMR deficient endometrial carcinomas.

CANCERS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

C. tropicalis promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system

Junxing Qu, Zhiheng Sun, Chen Peng, Daoqian Li, Wenyue Yan, Zhen Xu, Yayi Hou, Sunan Shen, Ping Chen, Tingting Wang

Summary: Candida tropicalis has been found to promote chemotherapy resistance in colon cancer by producing lactate and inhibiting the expression of MLH1, providing a new insight into improving the efficacy of colorectal cancer chemotherapy.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Editorial Material Oncology

Is sidedness prognostically important across all stages of colorectal cancer?

David J. Kerr, Enric Domingo, Rachel Kerr

LANCET ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Rachel S. Kerr, Sharon Love, Eva Segelov, Elaine Johnstone, Beverly Falcon, Peter Hewett, Andrew Weaver, David Church, Claire Scudder, Sarah Pearson, Patrick Julier, Francesco Pezzella, Ian Tomlinson, Enric Domingo, David J. Kerr

LANCET ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis

Sebastian May-Wilson, Amit Sud, Philip J. Law, Kimmo Palin, Sari Tuupanen, Alexandra Gylfe, Ulrika A. Hanninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti-Pekka Sarin, Johan G. Eriksson, Harri Rissanen, Paul Knekt, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Samuli Ripatti, Aarno Palotie, Laura Renkonen-Sinisalo, Anna Lepisto, Jan Bohm, Jukka-Pekka Mecklin, Nada A. Al-Tassan, Claire Palles, Susan M. Farrington, Maria N. Timofeeva, Brian F. Meyer, Salma M. Wakil, Harry Campbell, Christopher G. Smith, Shelley Idziaszczyk, Timothy S. Maughan, David Fisher, Rachel Kerr, David Kerr, Michael N. Passarelli, Jane C. Figueiredo, Daniel D. Buchanan, Aung K. Win, John L. Hopper, Mark A. Jenkins, Noralane M. Lindor, Polly A. Newcomb, Steven Gallinger, David Conti, Fred Schumacher, Graham Casey, Lauri A. Aaltonen, Jeremy P. Cheadle, Ian P. Tomlinson, Malcolm G. Dunlop, Richard S. Houlston

EUROPEAN JOURNAL OF CANCER (2017)

添加到收藏夹

Article Oncology

Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci

Tomas Tanskanen, Linda van den Berg, Niko Valimaki, Mervi Aavikko, Eivind Ness-Jensen, Kristian Hveem, Yvonne Wettergren, Elinor Bexe Lindskog, Neeme Tonisson, Andres Metspalu, Kaisa Silander, Giulia Orlando, Philip J. Law, Sari Tuupanen, Alexandra E. Gylfe, Ulrika A. Hanninen, Tatiana Cajuso, Johanna Kondelin, Antti-Pekka Sarin, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Samuli Ripatti, Aarno Palotie, Heikki Jarvinen, Laura Renkonen-Sinisalo, Anna Lepisto, Jan Bohm, Jukka-Pekka Mecklin, Nada A. Al-Tassan, Claire Palles, Lynn Martin, Ella Barclay, Albert Tenesa, Susan M. Farrington, Maria N. Timofeeva, Brian F. Meyer, Salma M. Wakil, Harry Campbell, Christopher G. Smith, Shelley Idziaszczyk, Tim S. Maughan, Richard Kaplan, Rachel Kerr, David Kerr, Daniel D. Buchanan, Aung K. Win, John Hopper, Mark A. Jenkins, Polly A. Newcomb, Steve Gallinger, David Conti, Fredrick R. Schumacher, Graham Casey, Jeremy P. Cheadle, Malcolm G. Dunlop, Ian P. Tomlinson, Richard S. Houlston, Kimmo Palin, Lauri A. Aaltonen

INTERNATIONAL JOURNAL OF CANCER (2018)

添加到收藏夹

Article Oncology

Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer

Henry Rodriguez-Broadbent, Philip J. Law, Amit Sud, Kimmo Palin, Sari Tuupanen, Alexandra Gylfe, Ulrika A. Hanninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti-Pekka Sarin, Samuli Ripatti, Johan G. Eriksson, Harri Rissanen, Paul Knekt, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Aarno Palotie, Laura Renkonen-Sinisalo, Anna Lepisto, Jan Bohm, Jukka-Pekka Mecklin, Nada A. Al-Tassan, Claire Palles, Lynn Martin, Ella Barclay, Susan M. Farrington, Maria N. Timofeeva, Brian F. Meyer, Salma M. Wakil, Harry Campbell, Christopher G. Smith, Shelley Idziaszczyk, Timothy S. Maughan, Richard Kaplan, Rachel Kerr, David Kerr, Michael N. Passarelli, Jane C. Figueiredo, Daniel D. Buchanan, Aung K. Win, John L. Hopper, Mark A. Jenkins, Noralane M. Lindor, Polly A. Newcomb, Steven Gallinger, David Conti, Fred Schumacher, Graham Casey, Lauri A. Aaltonen, Jeremy P. Cheadle, Ian P. Tomlinson, Malcolm G. Dunlop, Richard S. Houlston

INTERNATIONAL JOURNAL OF CANCER (2017)

添加到收藏夹

Article Oncology

The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial

Anouck Huijbers, Gabi W. van Pelt, Rachel S. Kerr, Elaine C. Johnstone, Rob A. E. M. Tollenaar, David J. Kerr, Wilma E. Mesker

JOURNAL OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Oncology

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Timothy J. Iveson, Rachel S. Kerr, Mark P. Saunders, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Claire Scudder, Kathleen Anne Boyd, Andrew Briggs, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S. Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K. Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S. Wasan, James Paul

LANCET ONCOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

A. Grothey, A. F. Sobrero, A. F. Shields, T. Yoshino, J. Paul, J. Taieb, J. Souglakos, Q. Shi, R. Kerr, R. Labianca, J. A. Meyerhardt, D. Vernerey, T. Yamanaka, I. Boukovinas, J. P. Meyers, L. A. Renfro, D. Niedzwiecki, T. Watanabe, V. Torri, M. Saunders, D. J. Sargent, T. Andre, T. Iveson

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Oncology

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Jose Robles-Zurita, Kathleen A. Boyd, Andrew H. Briggs, Timothy Iveson, Rachel S. Kerr, Mark P. Saunders, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Eva Segelov, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S. Dhadda, Rob Hughes, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K. Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S. Wasan, James Paul

BRITISH JOURNAL OF CANCER (2018)

添加到收藏夹

Article Oncology

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna Bendel, Guillem Argiles, Niofi C. Tebbutt, Mafia Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark Kozloff, Neil H. Segal, Alberto Sobrero, Yibing Yan, Llsung Chang, Anne Uyei, Louise Roberts, Fortunato Ciardieffo

LANCET ONCOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Philip J. Law, Maria Timofeeva, Ceres Fernandez-Rozadilla, Aria Timofeeva, Peter Broderick, James Studd, Juan Fernandez-Tajes, Susan Farrington, Victoria Svinti, Claire Palles, Giulia Orlando, Amit Sud, Amy Holroyd, Steven Penegar, Evropi Theodoratou, Peter Vaughan-Shaw, Harry Campbell, Lina Zgaga, Caroline Hayward, Archie Campbell, Sarah Harris, Ian J. Deary, Ohn Starr, Laura Gatcombe, Maria Pinna, Sarah Briggs, Lynn Martin, Emma Jaeger, Archana Sharma-Oates, James East, Simon Leedham, Roland Arnold, Elaine Johnstone, Haitao Wang, David Kerr, Rachel Kerr, Tim Maughan, Richard Kaplan, Nada Al-Tassan, Kimmo Palin, Ulrika A. Hanninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti-Pekka Sarin, Johan G. Eriksson, Harri Rissanen, Paul Knekt, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Samuli Ripatti, Aarno Palotie, Laura Renkonen-Sinisalo, Anna Lepisto, Jan Bohm, Jukka-Pekka Mecklin, Daniel D. Buchanan, Aung-Ko Win, John Hopper, Mark E. Jenkins, Noralane M. Lindor, Polly A. Newcomb, Steven Gallinger, David Duggan, Graham Casey, Per Hoffmann, Markus M. Nothen, Karl-Heinz Jockel, Douglas F. Easton, Paul D. P. Pharoah, Julian Peto, Federico Canzian, Anthony Swerdlow, Rosalind A. Eeles, Zsofia Kote-Jarai, Kenneth Muir, Nora Pashayan, Andrea Harkin, Karen Allan, John McQueen, James Paul, Timothy Iveson, Mark Saunders, Katja Butterbach, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, Iva Kirac, Petar Matosevic, Philipp Hofer, Stefanie Brezina, Andrea Gsur, Jeremy P. Cheadle, Lauri A. Aaltonen, Ian Tomlinson, Richard S. Houlston, Malcolm G. Dunlop, Brian E. Henderson, Christopher A. Haiman, Fredrick R. Schumacher, Ali Amin Al Olama, Sara Benlloch, Sonja Berndt, David Conti, Fredrik Wiklund, Stephen Chanock, Susan Gapstur, Victoria L. Stevens, Catherine M. Tangen, Jyotsna Batra, Judith Clements, Henrik Gronberg, Johanna Schleutker, Demetrius Albanes, Alicja Wolk, Catharine West, Lorelei Mucci, Geraldine Cancel-Tassin, Stella Koutros, Karina Dalsgaard Sorensen, Eli Marie Grindeda, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan, Ruth C. Travis, Robert J. Hamilton, Sue Ann Ingles, Barry S. Rosenstein, Yong-Jie Lu, Graham G. Giles, Adam S. Kibel, Ana Vega, Manolis Kogevinas, Kathryn L. Penney, Jong Y. Park, Janet L. Stanford, Cezary Cybulski, Borge G. Nordestgaard, Christiane Maier, Jeri Kim, Esther M. John, Manuel R. Teixeira, Susan L. Neuhausen, Kim De Ruyck, Azad Razack, Lisa F. Newcomb, Marija Gamulin, Radka Kaneva, Nawaid Usmani, Frank Claessens, Paul A. Townsend, Manuela Gago-Dominguez, Monique J. Roobol, Florence Menegaux, Kay-Tee Khaw, Lisa Cannon-Albright, Hardev Pandha, Stephen N. Thibodeau

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Health Care Sciences & Services

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT

Timothy Ivesono, Kathleen A. Boydo, Rachel S. Kerro, Jose Robles-Zuritao, Mark P. Saunders, Andrew H. Briggso, Jim Cassidyo, Niels Henrik Hollandero, Josep Taberneroo, Andrew Haydon, Bengt Glimeliuso, Andrea Harkino, Karen Allano, John McQueeno, Sarah Pearsono, Ashita Waterstono, Louise Medleyo, Charles Wilsono, Richard Elliso, Sharadah Essapen, Amandeep S. Dhaddao, Mark Harrison, Stephen Falko, Sherif Raoufo, Charlotte Rees, Rene K. Oleseno, David Proppero, John Bridgewatero, Ashraf Azzabio, David Farrugiao, Andrew Webbo, David Cunninghamo, Tamas Hickish, Andrew Weavero, Simon Gollins, Harpreet Wasano, James Paulo

HEALTH TECHNOLOGY ASSESSMENT (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Enric Domingo, Carme Camps, Pamela J. Kaisaki, Marie J. Parsons, Dmitri Mouradov, Melissa M. Pentony, Seiko Makino, Michelle Palmieri, Robyn L. Ward, Nicholas J. Hawkins, Peter Gibbs, Hanne Askautrud, Dahmane Oukrif, Haitao Wang, Joe Wood, Evie Tomlinson, Yasmine Bark, Kulvinder Kaur, Elaine C. Johnstone, Claire Palles, David N. Church, Marco Novelli, Havard E. Danielsen, Jon Sherlock, David Kerr, Rachel Kerr, Oliver Sieber, Jenny C. Taylor, Ian Tomlinson

LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

Enric Domingo, Luke Freeman-Mills, Emily Rayner, Mark Glaire, Sarah Briggs, Louis Vermeulen, Evelyn Fessler, Jan Paul Medema, Arnoud Boot, Hans Morreau, Tom van Wezel, Gerrit-Jan Liefers, Ragnhild A. Lothe, Stine A. Danielsen, Anita Sveen, Arild Nesbakken, Inti Zlobec, Alessandro Lugli, Viktor H. Koelzer, Martin D. Berger, Sergi Casteilvi-Bel, Jenifer Munoz, Marco de Bruyn, Hans W. Nijman, Marco Novelli, Kay Lawson, Dahtnane Oukrif, Eleni Frangou, Peter Dutton, Sabine Tejpar, Mauro Delorenzi, Rachel Kerr, David Kerr, Ian Tomlinson, David N. Church

LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)

添加到收藏夹

Article Oncology

Prognostic markers for colorectal cancer: estimating ploidy and stroma

H. E. Danielsen, T. S. Hveem, E. Domingo, M. Pradhan, A. Kleppe, R. A. Syvertsen, I. Kostolomov, J. A. Nesheim, H. A. Askautrud, A. Nesbakken, R. A. Lothe, A. Svindland, N. Shepherd, M. Novelli, E. Johnstone, I. Tomlinson, R. Kerr, D. J. Kerr

ANNALS OF ONCOLOGY (2018)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.